News

An international team has created a detailed molecular map of hypertrophic cardiomyopathy, one of the most common forms of heart disease. Their findings, published in “Science Translational Medicine,” identify biological pathways that could pave the way for more precise treatments.

Invaginations of the cell membrane called caveolae protect cells from mechanical stress, allow nutrients to enter the cell, and serve as signaling hubs. The teams of Oliver Daumke and Misha Kudryashev now describe in “Nature Communications” the structure of a protein chain that stabilizes caveolae.

Klaus Rajewsky is among this year’s winners of Emory University's Max Cooper Prize in Immunology, which recognizes scientists for their “transformative and revolutionary achievements.” The three winners will be formally honored on Sept. 29, 2026, with a $100,000 prize to be shared equally.

Since August 2026, Stefanie Seltmann has headed our new Data, Information and Publication Services department. In this interview, she explains what her team does and why our researchers, and science as a whole, stand to benefit.

Immunotherapies strengthen the body’s own anti-cancer defenses in a highly targeted manner. In...

Around 65 group leaders and PIs have gone through a new instrument developed as part of Strategy 2030: the 360° leadership feedback process. An interview with Group Leader and Associate Director of Talent Management Katja Simon on how to give and receive feedback.

Marie Skłodowska-Curie Actions Postdoctoral Fellowships are intended to support careers, foster research excellence, and provide international and interdisciplinary advanced training through cross-border mobility. Sara De Vincentiis in the Gouti lab is among this year’s winners.

Nikolaus Rajewsky and his team have built a search engine that can scan data from millions of single cells from thousands of experiments worldwide in seconds. The tool, described in “Nature,” makes it possible to answer previously impossible questions about RNA biology.

A seven protein “signature” in blood can indicate successful treatment for vasculitis. The Mertins, Forslund and Kettritz labs report in “Nature Communications” how they used proteomics and AI to identify biomarkers, which could enable more personalized treatment with fewer side effects.

One week, two topics, and plenty of new experiences: 25 young people take a deep dive into research on rare diseases and immunology at the Life Science Learning Lab “Gläsernes Labor,” including by analyzing their own genes.